Your browser doesn't support javascript.
loading
Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years.
Masarova, Lucia; Bose, Prithviraj; Pemmaraju, Naveen; Zhou, Lingsha; Pierce, Sherry; Estrov, Zeev; Kantarjian, Hagop; Verstovsek, Srdan.
Afiliación
  • Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhou L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Acta Haematol ; 146(6): 522-529, 2023.
Article en En | MEDLINE | ID: mdl-37699357
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Anemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Acta Haematol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Anemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Acta Haematol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos